PHVS
Pharvaris BV
NASDAQ: PHVS · HEALTHCARE · BIOTECHNOLOGY
$34.91
+1.34% today
Updated 2026-08-07
Market cap
$2.28B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.12
Dividend yield
—
52W range
$20 – $37
Volume
0.4M
WallStSmart proprietary scores
25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C7.0
Quality
B+3.0
Profitability
D5.0
Valuation
C+1/9
Piotroski F-Score
Weak
1.9
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →211 stocks currently score above 75
Price targets
Analyst target
$47.93
+37.30%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
3 Strong Buy9 Buy1 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-49.62M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-76.33M | $-100.88M | $-134.22M | $-175.70M | $-39.85M |
| EPS | — | — | — | — | $-3.12 |
| Free cash flow | $-67.29M | $-93.14M | $-120.67M | $-137.24M | $-49.62M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Pharvaris BV trades at $34.91. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of 1.87, it sits in the grey zone.
Frequently asked questions
What is Pharvaris BV's stock price?
Pharvaris BV (PHVS) trades at $34.91.
Is Pharvaris BV overvalued?
Pharvaris BV carries a Smart Value Score of 25/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Pharvaris BV (PHVS)?
The 12-month analyst consensus target is $47.93, about 37.3% above the current $34.91. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Pharvaris BV's Altman Z-Score is 1.87, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-71.60%
Beta-2.34
50D MA$32.70
200D MA$27.96
Shares out0.07B
Float0.04B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—